MDs and PhDs, thoughts please? In Newsweek today. Apologies if this has been posted...I got all excited because of the teaser line but then find out it's not Cytodyn...and they've only done mouse studies...but it's been published already in a Nature journal...why is *that* getting the Newsweek treatment and not Leronlimab?

https://www.newsweek.com/antibody-that-blocks...LEhnPA1aNc